Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Bio-Techne Corp (TECH) had Stock-Based Compensation of $36.13M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$311.42M |
|
$51.05M |
|
$103.13M |
|
$208.29M |
|
$235.92M |
|
$75.50M |
|
$-4.27M |
|
$71.22M |
|
$71.22M |
|
$51.05M |
|
$51.05M |
|
$51.05M |
|
$51.05M |
|
$75.50M |
|
$99.66M |
|
156.33M |
|
157.40M |
|
$0.33 |
|
$0.32 |
|
| Balance Sheet Financials | |
$688.05M |
|
$232.99M |
|
$1.86B |
|
$2.55B |
|
$153.28M |
|
$200.00M |
|
$312.02M |
|
$465.30M |
|
$2.09B |
|
$788.43M |
|
$2.09B |
|
156.52M |
|
| Cash Flow Statement Financials | |
$196.66M |
|
$-11.13M |
|
$-135.91M |
|
$162.19M |
|
$209.82M |
|
$47.63M |
|
|
Stock-Based Compensation |
$36.13M |
$-37.43M |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.49 |
|
-- |
|
-- |
|
0.09 |
|
0.10 |
|
66.88% |
|
24.24% |
|
24.24% |
|
-- |
|
22.87% |
|
16.39% |
|
$176.29M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.51 |
|
1.45 |
|
62.01 |
|
2.45% |
|
6.47% |
|
2.00% |
|
2.23% |
|
$13.32 |
|
$1.12 |
|
$1.25 |
|